121 related articles for article (PubMed ID: 24481145)
1. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with breast cancer susceptibility and prognosis.
Li X; Kong X; Jiang L; Ma T; Yan S; Yuan C; Yang Q
Cell Physiol Biochem; 2014; 33(1):165-72. PubMed ID: 24481145
[TBL] [Abstract][Full Text] [Related]
2. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with ovarian cancer susceptibility.
Yan S; Yuan C; Yang Q; Li X; Yang N; Liu X; Dong R; Zhang X; Yuan Z; Zhang N; Kong B
Oncol Rep; 2015 Oct; 34(4):2151-5. PubMed ID: 26252839
[TBL] [Abstract][Full Text] [Related]
3. A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.
Tang Q; Zhao Y; Wang Y; Wei M
Med Oncol; 2014 Nov; 31(11):267. PubMed ID: 25270285
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of calcium-sensing receptor in women with breast cancer.
Campos-Verdes LM; da Silva-Sampaio JP; Costa-Silva DR; de Oliveira VA; Junior AMC; Silva VC; Alencar AP; Campelo V; Lopes-Costa PV; Gebrim LH; da Silva BB
Med Oncol; 2018 Jan; 35(3):23. PubMed ID: 29387985
[TBL] [Abstract][Full Text] [Related]
5. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
6. A genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with stone multiplicity in calcium nephrolithiasis.
Chou YH; Woon PY; Chen WC; Hsu YW; Chang JM; Hwang DY; Chiu YC; Kuo HC; Chang WP; Hou MF; Liu ME; Chang JG; Chang WC
PLoS One; 2011; 6(9):e25227. PubMed ID: 21966463
[TBL] [Abstract][Full Text] [Related]
7. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
[TBL] [Abstract][Full Text] [Related]
8. Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians.
Rizk SM; Shahin NN; Shaker OG
PLoS One; 2016; 11(3):e0151901. PubMed ID: 26999517
[TBL] [Abstract][Full Text] [Related]
9. CASR rs1801725 polymorphism is associated with the risk and prognosis of colorectal cancer: A case-control study.
Diao YE; Xu Q
J Clin Lab Anal; 2020 Nov; 34(11):e23463. PubMed ID: 32648293
[TBL] [Abstract][Full Text] [Related]
10. [Association of single nucleotide polymorphisms in PAI-1 with breast cancer susceptibility and prognosis].
Chen YL; Jia YM; Xie YT; Li Y; Fang WG; Tian XX
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):533-9. PubMed ID: 27510778
[TBL] [Abstract][Full Text] [Related]
11. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
Riaz M; Berns EM; Sieuwerts AM; Ruigrok-Ritstier K; de Weerd V; Groenewoud A; Uitterlinden AG; Look MP; Klijn JG; Sleijfer S; Foekens JA; Martens JW
Breast Cancer Res Treat; 2012 Jun; 133(3):843-51. PubMed ID: 21748294
[TBL] [Abstract][Full Text] [Related]
12. Correlations of
Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
[TBL] [Abstract][Full Text] [Related]
14. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
15. Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients.
Wang L; Widatalla SE; Whalen DS; Ochieng J; Sakwe AM
BMC Cancer; 2017 Aug; 17(1):511. PubMed ID: 28764683
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
17. Potential Impact of Vascular Endothelial Growth Factor Gene Variation (-2578C>A) on Breast Cancer Susceptibility in Saudi Arabia: a Case-Control Study.
Al Balawi IA; Mir R; Abu-Duhier FM
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1135-1143. PubMed ID: 29699375
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
19. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
Bayram S; Sümbül AT; Dadaş E
Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in calcium-sensing receptor and risk for colon cancer.
Dong LM; Ulrich CM; Hsu L; Duggan DJ; Benitez DS; White E; Slattery ML; Caan BJ; Potter JD; Peters U
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2755-65. PubMed ID: 18843020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
